Clinical trial
Open-Label Study of SPI-1005 for the Treatment of Meniere's Disease
NCT06859788 is registered in ClinicalTrials.gov with Sound Pharmaceuticals, Incorporated as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-Label Study of SPI-1005 for the Treatment of Meniere's Disease
- Lead sponsor
- Sound Pharmaceuticals, Incorporated
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- October 29, 2025
- Completion date
- December 31, 2026
- Enrollment
- 200 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
meniere's disease, ménière's disease